Quick Takeaways
- INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A for Nektar Therapeutics Common Stock, par value $0.0001 per share (NKTR).
- Disclosed ownership: 3%.
- Date of event: 30 Sep 2025.
INTEGRATED CORE STRATEGIES (US) LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Nektar Therapeutics Common Stock, par value $0.0001 per share (NKTR)
- Filing Manager
- INTEGRATED CORE STRATEGIES (US) LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- NKTR
- Shares outstanding
- 19,033,133 shares
- Disclosed Ownership
- 570,994 shares
- Ownership
- 3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 28 Oct 2025, 16:10:23 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 03 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"INTEGRATED CORE STRATEGIES (US) LLC disclosed 3% ownership in Nektar Therapeutics Common Stock, par value $0.0001 per share (NKTR) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 03 Jul 2025.
- Current filing was accepted on 28 Oct 2025, 16:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 1.8% | 333,576 | 0 | 333,576 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 3% | 570,994 | 0 | 570,994 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 3% | 570,994 | 0 | 570,994 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 3% | 570,994 | 0 | 570,994 | /s/ Israel A. Englander | Israel A. Englander |